Form 8-K - Current report:
SEC Accession No. 0001104659-24-103925
Filing Date
2024-09-30
Accepted
2024-09-30 07:00:33
Documents
14
Period of Report
2024-09-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2425053d1_8k.htm   iXBRL 8-K 34176
2 EXHIBIT 10.1 tm2425053d1_ex10-1.htm EX-10.1 1619874
  Complete submission text file 0001104659-24-103925.txt   2160739

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA irwd-20240927.xsd EX-101.SCH 3033
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE irwd-20240927_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE irwd-20240927_pre.xml EX-101.PRE 22371
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2425053d1_8k_htm.xml XML 3696
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

EIN.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34620 | Film No.: 241336626
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)